When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LIXT - LIXTE Biotechnology stock shoots on $5.8M direct offering priced ATM
Lixte Biotechnology Holdings Inc.
LIXTE Biotechnology Holdings (LIXT +86.4%) stock price rockets as it entered into definitive agreements for the purchase and sale of 2.9M shares, at a purchase price of $2/share, in a registered direct offering. The gross proceeds of ~$5.8M will be used for working capital and general expenses including further development of its lead clinical compound LB-100. The closing of the offering is expected to occur on or about April 14, 2022.